tiprankstipranks
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market
SANA
Sana Biotechnology
RESEARCH TOOLSreports
Want to see SANA full AI Analyst Report?

Sana Biotechnology (SANA) Stock Forecast & Price Target

875 Followers
See the Price Targets and Ratings of:

SANA Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Sana
Biotechnology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SANA Stock 12 Month Forecast

Average Price Target

$8.68
▲(146.54% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Sana Biotechnology in the last 3 months. The average price target is $8.68 with a high forecast of $16.00 and a low forecast of $3.07. The average price target represents a 146.54% change from the last price of $3.52.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.678333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.07</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.27,4.24923076923077,5.228461538461539,6.207692307692308,7.186923076923077,8.166153846153847,9.145384615384616,10.124615384615385,11.103846153846154,12.083076923076923,13.062307692307693,14.041538461538462,15.02076923076923,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.27,3.686025641025641,4.102051282051282,4.518076923076923,4.934102564102564,5.350128205128205,5.766153846153847,6.1821794871794875,6.598205128205128,7.014230769230769,7.43025641025641,7.846282051282051,8.262307692307692,{"y":8.678333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.27,3.2546153846153847,3.2392307692307694,3.223846153846154,3.2084615384615383,3.193076923076923,3.1776923076923076,3.1623076923076923,3.146923076923077,3.1315384615384616,3.1161538461538463,3.1007692307692305,3.085384615384615,{"y":3.07,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.83,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.07,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.15,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.05,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.27,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$16.00Average Price Target$8.68Lowest Price Target$3.07
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on SANA
Maxwell Skor
Morgan Stanley
Morgan Stanley
$12→$3.07
Buy
-12.78%
Downside
Reiterated
05/18/26
Sana Biotechnology (SANA) Gets a Buy from Morgan Stanley
Wedbush Analyst forecast on SANA
Martin Fan
Wedbush
Wedbush
$7
Buy
98.86%
Upside
Reiterated
05/13/26
Sana Biotechnology (SANA) Receives a Buy from Wedbush
Bank of America Securities Analyst forecast on SANA
Alec Stranahan
Bank of America Securities
Bank of America Securities
$7
Buy
98.86%
Upside
Reiterated
05/12/26
Bank of America Securities Keeps Their Buy Rating on Sana Biotechnology (SANA)
H.C. Wainwright Analyst forecast on SANA
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
$7
Buy
98.86%
Upside
Reiterated
05/12/26
Sana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target
TD Cowen Analyst forecast on SANA
Marc Frahm
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/11/26
Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027
Rodman & Renshaw Analyst forecast on SANA
Michael King
Rodman & Renshaw
Rodman & Renshaw
$16
Buy
354.55%
Upside
Initiated
05/11/26
Sana Biotechnology initiated with a Buy at Rodman & RenshawSana Biotechnology initiated with a Buy at Rodman & Renshaw
Citi Analyst forecast on SANA
Samantha Semenkow
Citi
Citi
$12
Buy
240.91%
Upside
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN) and Sana Biotechnology (NASDAQ: SANA)
Citizens JMP Analyst forecast on SANA
Reni Benjamin
Citizens JMP
Citizens JMP
$5→$8
Buy
127.27%
Upside
Reiterated
10/30/25
Sana Biotechnology price target raised to $8 from $5 at Citizens JMPSana Biotechnology price target raised to $8 from $5 at Citizens JMP
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on SANA
Maxwell Skor
Morgan Stanley
Morgan Stanley
$12→$3.07
Buy
-12.78%
Downside
Reiterated
05/18/26
Sana Biotechnology (SANA) Gets a Buy from Morgan Stanley
Wedbush Analyst forecast on SANA
Martin Fan
Wedbush
Wedbush
$7
Buy
98.86%
Upside
Reiterated
05/13/26
Sana Biotechnology (SANA) Receives a Buy from Wedbush
Bank of America Securities Analyst forecast on SANA
Alec Stranahan
Bank of America Securities
Bank of America Securities
$7
Buy
98.86%
Upside
Reiterated
05/12/26
Bank of America Securities Keeps Their Buy Rating on Sana Biotechnology (SANA)
H.C. Wainwright Analyst forecast on SANA
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
$7
Buy
98.86%
Upside
Reiterated
05/12/26
Sana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target
TD Cowen Analyst forecast on SANA
Marc Frahm
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/11/26
Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027
Rodman & Renshaw Analyst forecast on SANA
Michael King
Rodman & Renshaw
Rodman & Renshaw
$16
Buy
354.55%
Upside
Initiated
05/11/26
Sana Biotechnology initiated with a Buy at Rodman & RenshawSana Biotechnology initiated with a Buy at Rodman & Renshaw
Citi Analyst forecast on SANA
Samantha Semenkow
Citi
Citi
$12
Buy
240.91%
Upside
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN) and Sana Biotechnology (NASDAQ: SANA)
Citizens JMP Analyst forecast on SANA
Reni Benjamin
Citizens JMP
Citizens JMP
$5→$8
Buy
127.27%
Upside
Reiterated
10/30/25
Sana Biotechnology price target raised to $8 from $5 at Citizens JMPSana Biotechnology price target raised to $8 from $5 at Citizens JMP
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sana Biotechnology

3 Months
Reni BenjaminCitizens JMP
Success Rate
7/12 ratings generated profit
58%
Average Return
+23.43%
Copying Reni Benjamin's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +23.43% per trade.
1 Year
Alec StranahanBank of America Securities
Success Rate
5/9 ratings generated profit
56%
Average Return
+20.17%
Copying Alec Stranahan's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +20.17% per trade.
2 Years
Samantha SemenkowCiti
Success Rate
5/13 ratings generated profit
38%
Average Return
-6.08%
Copying Samantha Semenkow's trades and holding each position for 2 Years would result in 38.46% of your transactions generating a profit, with an average return of -6.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SANA Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
2
1
6
8
12
Buy
3
1
2
2
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
2
8
10
16
In the current month, SANA has received 16 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SANA average Analyst price target in the past 3 months is 8.68.
Each month's total comprises the sum of three months' worth of ratings.

SANA Financial Forecast

SANA Earnings Forecast

Next quarter’s earnings estimate for SANA is -$0.15 with a range of -$0.17 to -$0.13. The previous quarter’s EPS was -$0.17. SANA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SANA has Performed in-line its overall industry.
Next quarter’s earnings estimate for SANA is -$0.15 with a range of -$0.17 to -$0.13. The previous quarter’s EPS was -$0.17. SANA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SANA has Performed in-line its overall industry.
No data currently available

SANA Sales Forecast

Next quarter’s sales forecast for SANA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SANA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SANA has Performed in-line its overall industry.
Next quarter’s sales forecast for SANA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SANA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SANA has Performed in-line its overall industry.

SANA Stock Forecast FAQ

What is SANA’s average 12-month price target, according to analysts?
Based on analyst ratings, Sana Biotechnology’s 12-month average price target is 8.68.
    What is SANA’s upside potential, based on the analysts’ average price target?
    Sana Biotechnology has 146.54% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SANA a Buy, Sell or Hold?
          Sana Biotechnology has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Sana Biotechnology’s price target?
            The average price target for Sana Biotechnology is 8.68. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $16.00 ,the lowest forecast is $3.07. The average price target represents 146.54% Increase from the current price of $3.52.
              What do analysts say about Sana Biotechnology?
              Sana Biotechnology’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of SANA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.